APA (7th ed.) Citation

Inciardi, R. M., Vaduganathan, M., Lombardi, C. M., Gussago, C., Agostoni, P., Ameri, P., . . . La Rovere, M. T. (2024). OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM‐HF registry. European Journal of Heart Failure, 26(8), 1707. https://doi.org/10.1002/ejhf.3260

Chicago Style (17th ed.) Citation

Inciardi, Riccardo M., et al. "OPTImal PHARMacological Therapy for Patients with Heart Failure: Rationale and Design of the OPTIPHARM‐HF Registry." European Journal of Heart Failure 26, no. 8 (2024): 1707. https://doi.org/10.1002/ejhf.3260.

MLA (9th ed.) Citation

Inciardi, Riccardo M., et al. "OPTImal PHARMacological Therapy for Patients with Heart Failure: Rationale and Design of the OPTIPHARM‐HF Registry." European Journal of Heart Failure, vol. 26, no. 8, 2024, p. 1707, https://doi.org/10.1002/ejhf.3260.